The experienced team at Pathena has been working together for over 15 years, with a strong international track record in entrepreneurship and venture capital in technology and digital health. They prefer to invest in seed-stage, early-stage, and later-stage companies operating in digital health and technology sectors based in Europe. Currently managing €70M in assets, their portfolio includes 13 active companies in fields such as respiratory diseases, patient's digital condition recognition, machine vision, robotics, and software. Pathena has had successful exits in the past, with trade sales to strategic players like Microsoft, Wipro, and Smith Micro. A portfolio overview is available on their website.